- Title
- Uridine diphosphate-glucose/P2Y₁₄R axis is a nonchemokine pathway that selectively promotes eosinophil accumulation
- Creator
- Foster, Paul S.; Tay, Hock L.; Hogan, Simon P.
- Relation
- The Journal of Clinical Investigation Vol. 131, Issue 7, no. e147735
- Publisher Link
- http://dx.doi.org/10.1172/JCI147735
- Publisher
- American Society for Clinical Investigation
- Resource Type
- journal article
- Date
- 2021
- Description
- Allergic asthma is a chronic inflammatory airway disease characterized by dysregulated type 2 immune responses, including degranulating airway eosinophils that induce tissue damage and airway hyperresponsiveness (AHR). The type 2 cytokines interleukin 5 (IL-5) and IL-13 and the eosinophil-specific chemokine CCL11/CCL24/CCL26 axis recruit, activate, and regulate eosinophils in the airways. In this issue of the JCI, Karcz et al. identified a mechanism involving the nucleotide sugar UDP-glucose (UDP-G) and the purinergic receptor P2Y14R in amplifying eosinophil accumulation in the lung. During type 2 inflammation, UDP-G activates P2Y14R on eosinophils, inducing the cells to move and migrate into the lung. Pharmacologically or genetically inhibiting P2Y14R on eosinophils attenuated eosinophil infiltration and AHR. Future experiments, including identifying additional type 2 factors regulating P2Y14R expression on lung eosinophils, are necessary to ascertain the impact of targeting P2Y14R as an alternative or adjunctive therapy to current type 2 biologics for the treatment of asthma.
- Subject
- allergic asthma; tissue damage; airway hyperresponsiveness; treatment; SDG 3; Sustainable Development Goals
- Identifier
- http://hdl.handle.net/1959.13/1463092
- Identifier
- uon:46635
- Identifier
- ISSN:0021-9738
- Language
- eng
- Reviewed
- Hits: 743
- Visitors: 736
- Downloads: 0
Collections
Goal 3: Good Health and Well-Being
| Thumbnail | File | Description | Size | Format |
|---|